| Product NDC: | 0065-0702 |
| Proprietary Name: | atropine sulfate |
| Non Proprietary Name: | atropine sulfate |
| Active Ingredient(s): | 10 mg/mL & nbsp; atropine sulfate |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0065-0702 |
| Labeler Name: | Alcon Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Start Marketing Date: | 20000612 |
| Package NDC: | 0065-0702-12 |
| Package Description: | 2 mL in 1 BOTTLE, PLASTIC (0065-0702-12) |
| NDC Code | 0065-0702-12 |
| Proprietary Name | atropine sulfate |
| Package Description | 2 mL in 1 BOTTLE, PLASTIC (0065-0702-12) |
| Product NDC | 0065-0702 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | atropine sulfate |
| Dosage Form Name | SOLUTION |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 20000612 |
| Marketing Category Name | UNAPPROVED DRUG OTHER |
| Labeler Name | Alcon Laboratories, Inc. |
| Substance Name | ATROPINE SULFATE |
| Strength Number | 10 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Anticholinergic [EPC],Cholinergic Antagonists [MoA],Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] |